Aneth Osward

Ms. Aneth Osward

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2024 in Journal of Public Health and Community Medicine
Verified
Journal Article
Closed access
PDF file
January G. MsemakweliJanuary G. Msemakweli
January G. Msemakweli
KMKhalid Mzuka
Khalid Mzuka
Aneth OswardAneth Osward
Aneth Osward
Antimicrobial resistance (AMR) is a critical global health threat that transcends human, animal, and environmental sectors, necessitating a One Health approach. AMR arises from the misuse and overuse of antimicrobial agents in clinical, veterinary, and environmental settings, resulting in treatment failures and heightened mortality rates. By 2050, AMR is projected to cause 10 million deaths annually and incur a global economic loss of 1 trillion USD. Low- and middle-income countries (LMICs) are expected to bear a significant burden, potentially accounting for 5 million of these deaths and facing substantial economic challenges due to limited access to healthcare resources and second-line antibiotics. In human health, excessive antibiotic prescriptions and hospital-acquired infections have been identified as major drivers of resistance, exacerbated by poor infection control and the lack of rapid diagnostic tools. Similarly, in veterinary medicine, the use of antimicrobials in livestock for disease prevention and growth promotion contributes significantly to AMR. Resistant bacteria from animals can transmit to humans through direct contact, the food chain, and environmental contamination. The environment further amplifies resistance through pharmaceutical waste, wastewater treatment inefficiencies, and the accumulation of resistant genes in ecosystems. Global efforts to address AMR include regulatory frameworks for prudent antimicrobial use in agriculture, human medicine, and waste management, alongside research into alternatives like phage therapy, immunotherapies, and improved diagnostics. Future solutions must focus on innovation, public engagement, and multi-sectoral collaboration to tackle the rising tide of resistance. The aim of this review is to explore the issue of Antimicrobial Resistance (AMR) from a One Health perspective, highlighting the challenges faced by low- and middle-income countries (LMICs).

3 January 2025 in Journal of Experimental and Laboratory Medicine
Verified
Journal Article
Closed access
Aneth OswardAneth Osward
Aneth Osward
January G. MsemakweliJanuary G. Msemakweli
January G. Msemakweli
Background and Aim: Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) are essential tests for diagnosing hemostatic disorders and monitoring anticoagulant therapy. However, delays in processing samples can affect result accuracy. This study aimed to assess the impact of plasma sample processing delays on PT and APTT results. Methods: An experimental study was conducted at Muhimbili National Hospital, with 100 plasma samples collected from healthy blood donors. Samples were processed within 4 hours (baseline) and stored at -20°C for retesting after 24 and 48 hours. PT and APTT results were compared using one-way ANOVA and non-parametric tests, with a significance threshold of p < 0.05. Data was collected and analyzed in 2024. Results: PT and APTT values increased with plasma storage time. At baseline, PT and APTT averaged 12.92 seconds and 28.92 seconds, respectively. After 24 hours, PT increased to 15.08 seconds and APTT to 32.28 seconds. At 48 hours, PT reached 17.72 seconds, and APTT was 38.28 seconds. One-way ANOVA showed significant differences in both PT and APTT across storage times (p < 0.001). Correlation analysis revealed a strong positive correlation between storage time and test results (PT: r = 0.852, APTT: r = 0.859). Non-parametric tests confirmed significant differences in PT and APTT between baseline and stored samples at 24 and 48 hours. Conclusion: Delays in processing plasma samples significantly affect PT and APTT results, emphasizing the need for timely testing within 4 hours to ensure accuracy.
1